Claris Biotherapeutics

Recent Financing

Series B

Recent Raise

$118M

Claris Biotherapeutics is a biotech developing CSB-001 (oremepermin alfa) eye drops to treat limbal stem cell deficiency and other front-of-eye diseases.

Founded 2018

New Jersey, United States

1-10

Private

clarisbio.com